Enantios (private company)
See something wrong or missing? Let us know
Offices:Zurich
Industry:BiotechHealth servicesManufacturing
Business model:B2B
Enantios is a Swiss biotech startup developing a new molecule characterization method that enables the complete characterization of complex molecules and aspects of the three dimensional structure which are not possible to resolve with other methods.
Investors:
we tracked 2 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 2.01M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Enantios
Name | Criteria | |
---|---|---|
![]() |
Bionomous
63%
|
|
![]() |
FinnAdvance
63%
|
|
![]() |
Ossiform
63%
|
|
![]() |
ViveBiotech
63%
|
|
![]() |
CellulaREvolution
63%
|
|
![]() |
ResoTher Pharma
63%
|
|
![]() |
SmartCatch
63%
|
|
![]() |
Molecule.one
63%
|
|
![]() |
Nanolyze
63%
|
|
![]() |
NuVision Biotherapies
63%
|
|